Inside-Out Control of Fc-Receptors.

Fc-receptors activation immunoglobulins inside-out control phagocytes priming

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 07 01 2019
accepted: 28 02 2019
entrez: 6 4 2019
pubmed: 6 4 2019
medline: 25 9 2020
Statut: epublish

Résumé

Receptors recognizing the Fc-part of immunoglobulins (FcR) are important in the engagement of phagocytes with opsonized micro-organisms, but they also play a major role in the pathogenesis of chronic inflammatory diseases. Different FcRs are specifically recognizing and binding the different classes of immunoglobulins, transmitting different signals into the cell. The function of IgG (FcγR's) and IgA (FcαR) recognizing receptors is controlled by cellular signals evoked by activation of heterologous receptors in a process generally referred to as inside-out control. This concept is clearly described for the regulation of integrin receptors. Inside-out control can be achieved at different levels by modulation of: (i) receptor affinity, (ii) receptor avidity/valency, (iii) interaction with signaling chains, (iv) interaction with other receptors and (v) localization in functionally different membrane domains. The inside-out control of FcRs is an interesting target for novel therapy by therapeutical antibodies as it can potentiate or decrease the functionality of the response to the antibodies depending on the mechanisms of the diseases they are applied for.

Identifiants

pubmed: 30949181
doi: 10.3389/fimmu.2019.00544
pmc: PMC6437074
doi:

Substances chimiques

Antibodies 0
Immunoglobulins 0
Receptors, Fc 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

544

Commentaires et corrections

Type : ErratumIn

Références

J Immunol. 2000 Jan 15;164(2):1020-8
pubmed: 10623852
Blood. 2000 Mar 15;95(6):2037-43
pubmed: 10706872
J Leukoc Biol. 2000 Nov;68(5):655-61
pubmed: 11073104
Annu Rev Immunol. 2001;19:275-90
pubmed: 11244038
Blood. 2001 Apr 15;97(8):2478-86
pubmed: 11290613
Blood. 2001 Jun 1;97(11):3478-83
pubmed: 11369640
Immunol Res. 2002;25(1):75-95
pubmed: 11868935
Am J Physiol Cell Physiol. 2002 Aug;283(2):C446-55
pubmed: 12107054
Trends Immunol. 2002 Aug;23(8):375-8
pubmed: 12133792
Annu Rev Immunol. 2003;21:177-204
pubmed: 12524384
Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4533-8
pubmed: 12676989
J Leukoc Biol. 2003 Jun;73(6):823-9
pubmed: 12773515
J Exp Med. 1992 May 1;175(5):1381-90
pubmed: 1314888
Clin Exp Immunol. 2003 Nov;134(2):344-50
pubmed: 14616797
Immunol Lett. 2003 Dec 15;90(2-3):137-43
pubmed: 14687715
Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10392-7
pubmed: 15229321
J Immunol. 2004 Aug 1;173(3):2068-77
pubmed: 15265942
Biochem Soc Trans. 2004 Nov;32(Pt 5):878-80
pubmed: 15494039
Annu Rev Immunol. 2005;23:197-223
pubmed: 15771570
Trends Immunol. 2007 Feb;28(2):66-73
pubmed: 17197236
Nat Rev Immunol. 2007 May;7(5):365-78
pubmed: 17438574
Nat Rev Immunol. 2007 Sep;7(9):715-25
pubmed: 17703228
Cell Signal. 2008 Apr;20(4):625-36
pubmed: 18207701
J Immunol. 2008 Sep 15;181(6):4080-8
pubmed: 18768864
Blood. 2009 May 7;113(19):4740-6
pubmed: 19064721
PLoS Pathog. 2009 Jun;5(6):e1000464
pubmed: 19503602
J Clin Immunol. 2010 Jan;30(1):1-9
pubmed: 19834792
Cell Immunol. 2010;261(2):153-8
pubmed: 20038460
Science. 2010 Jan 1;327(5961):46-50
pubmed: 20044567
Annu Rev Biophys. 2010;39:265-89
pubmed: 20192768
Blood. 2010 Dec 9;116(24):5327-33
pubmed: 20805361
J Thromb Haemost. 2011 Jul;9 Suppl 1:20-25
pubmed: 21781238
Expert Opin Biol Ther. 2012 Jan;12(1):113-8
pubmed: 22136436
Cytometry B Clin Cytom. 2012 May;82(3):132-8
pubmed: 22173928
FEBS Lett. 1990 Sep 17;270(1-2):49-52
pubmed: 2226788
Trends Pharmacol Sci. 2012 Sep;33(9):502-9
pubmed: 22749712
Blood. 2012 Nov 22;120(22):4421-31
pubmed: 22955924
Immunobiology. 2012 Nov;217(11):1067-79
pubmed: 22964232
J Immunol. 2013 Sep 15;191(6):2871-8
pubmed: 23945142
Physiol Rep. 2014 Mar 20;2(3):e00241
pubmed: 24760504
Cell Host Microbe. 2014 May 14;15(5):526-36
pubmed: 24832448
J Exp Med. 2014 Jun 30;211(7):1281-8
pubmed: 24889202
Hum Immunol. 2014 Aug;75(8):785-90
pubmed: 24945596
Curr Top Microbiol Immunol. 2014;382:221-35
pubmed: 25116102
Curr Top Microbiol Immunol. 2014;382:393-417
pubmed: 25116110
J Immunol. 1989 Jul 15;143(2):571-8
pubmed: 2525588
J Immunol. 1989 Apr 1;142(7):2365-9
pubmed: 2538508
J Allergy Clin Immunol. 2016 Jan;137(1):75-86.e8
pubmed: 26194544
Immunol Rev. 2015 Nov;268(1):6-24
pubmed: 26497510
Immunol Rev. 2015 Nov;268(1):66-73
pubmed: 26497513
Immunol Rev. 2015 Nov;268(1):74-87
pubmed: 26497514
Immunol Rev. 2015 Nov;268(1):311-27
pubmed: 26497530
Immunity. 2016 Mar 15;44(3):463-475
pubmed: 26982354
J Immunol Res. 2016;2016:2908034
pubmed: 27034964
Dev Cell. 2016 Jul 25;38(2):161-9
pubmed: 27459068
Cell Mol Life Sci. 2017 Mar;74(5):837-847
pubmed: 27639381
Sci Transl Med. 2016 Nov 16;8(365):365ra158
pubmed: 27856797
J Inflamm Res. 2016 Nov 16;9:209-219
pubmed: 27895507
Allergy Asthma Clin Immunol. 2017 Jan 6;13:2
pubmed: 28070196
Trends Immunol. 2017 May;38(5):358-372
pubmed: 28385520
Annu Rev Immunol. 2017 Apr 26;35:285-311
pubmed: 28446061
Protein Cell. 2018 Jan;9(1):86-120
pubmed: 28822103
Exp Cell Res. 2018 Jan 1;362(1):121-131
pubmed: 29137913
J Biol Chem. 2018 Mar 9;293(10):3477-3489
pubmed: 29330305
J Leukoc Biol. 2005 May;77(5):787-799
pubmed: 29350792
J Leukoc Biol. 2018 Feb 6;:null
pubmed: 29406570
J Biol Chem. 2018 Mar 9;293(10):3490-3491
pubmed: 29523693
Front Immunol. 2018 Mar 19;9:553
pubmed: 29616041
Nature. 1988 Jun 16;333(6174):667-9
pubmed: 2967437
Sci Signal. 2018 Jul 24;11(540):null
pubmed: 30042128
Front Immunol. 2019 Jan 31;9:3191
pubmed: 30766540
J Immunol. 1987 May 15;138(10):3443-7
pubmed: 3571976
J Exp Med. 1984 Dec 1;160(6):1901-18
pubmed: 6096477
Blood. 1995 Apr 15;85(8):2202-11
pubmed: 7718892
J Mol Biol. 1995 Apr 7;247(4):597-603
pubmed: 7723017
J Biol Chem. 1995 May 5;270(18):10671-9
pubmed: 7738004
Eur J Immunol. 1995 Jan;25(1):117-25
pubmed: 7843220
J Immunol. 1994 Sep 15;153(6):2729-35
pubmed: 8077677
Blood. 1994 Mar 15;83(6):1650-5
pubmed: 8123856
J Biol Chem. 1993 Sep 25;268(27):19931-4
pubmed: 8376355
J Clin Invest. 1993 Oct;92(4):1681-5
pubmed: 8408621
Blood. 1993 May 1;81(9):2413-9
pubmed: 8481520
J Biol Chem. 1995 Dec 15;270(50):29781-7
pubmed: 8530370
Blood. 1996 May 1;87(9):3593-9
pubmed: 8611682
J Am Soc Nephrol. 1996 Aug;7(8):1091-7
pubmed: 8866399
Blood. 1996 Dec 1;88(11):4330-7
pubmed: 8943870
J Immunol. 1996 Dec 15;157(12):5660-5
pubmed: 8955219
J Biol Chem. 1997 Jun 6;272(23):14740-6
pubmed: 9169439
Immunol Lett. 1997 Jun 1;57(1-3):27-31
pubmed: 9232421
J Exp Med. 1997 Dec 15;186(12):1957-63
pubmed: 9396764
J Leukoc Biol. 1998 May;63(5):521-33
pubmed: 9581795
J Immunol. 1998 Sep 15;161(6):2716-22
pubmed: 9743328
J Immunol. 1998 Dec 15;161(12):6768-74
pubmed: 9862707
Cell. 1998 Dec 23;95(7):875-8
pubmed: 9875841
Mol Immunol. 1998 Oct;35(14-15):989-96
pubmed: 9881694

Auteurs

Leo Koenderman (L)

Department of Respiratory Medicine and Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH